HT
RIGL icon

HAP Trading’s Rigel Pharmaceuticals RIGL Stock Holding History

HAP Trading’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,996
Closed -$271K – 2675
2021
Q4 		$265K Sell
9,996
-1,946
-16% -$58.7K 0.01% 916
2021
Q3 		$434K Buy
11,942
+826
+7% +$32.5K 0.01% 729
2021
Q2 		$482K Sell
11,116
-1,327
-11% -$50.1K 0.02% 655
2021
Q1 		$426K Buy
12,443
+1,851
+17% +$73.3K 0.02% 541
2020
Q4 		$371K Buy
10,592
+592
+6% +$17.1K 0.01% 733
2020
Q3 		$240K Buy
+10,000
New +$246K 0.01% 584
2020
Q1 		– Sell
-9,893
Closed -$212K – 1465
2019
Q4 		$212K Buy
+9,893
New +$204K 0.01% 451
2016
Q4 		– Sell
-30,757
Closed -$1.13M – 1182
2016
Q3 		$1.13M Buy
+30,757
New +$882K 0.04% 247

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

HAP Trading's RIGL Position: Q1 2022 in Review

HAP Trading sold out of Rigel Pharmaceuticals (RIGL) in Q1 2022, closing a stake of 9,996 shares — an estimated $271K sold.

HAP Trading first reported a position in RIGL in Q3 2016 and held it in 8 quarters. The position peaked at $1.13M in Q3 2016. 163 funds tracked by Wall St. Rank hold RIGL as of Q1 2022.

  • HAP Trading reported no remaining Rigel Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • HAP Trading sold 9,996 Rigel Pharmaceuticals shares in Q1 2022, an estimated $271K.
  • HAP Trading first reported a position in Rigel Pharmaceuticals in Q3 2016 and held it in 8 quarters.
  • HAP Trading's Rigel Pharmaceuticals position peaked at $1.13M in Q3 2016.
  • 163 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2022.

Based on HAP Trading's 13F filing for Q1 2022, filed 12 May 2022.